Nurix Therapeutics Inc’s recently made public that its Chief Legal Officer Ring Christine unloaded Company’s shares for reported $0.13 million on Oct 01 ’24. In the deal valued at $22.23 per share,5,760 shares were sold. As a result of this transaction, Ring Christine now holds 24,592 shares worth roughly $-0.62 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, CHRISTINE RING bought 9,050 shares, generating $203,354 in total proceeds.
Before that, Ring Christine sold 9,050 shares. Nurix Therapeutics Inc shares valued at $225,736 were divested by the Chief Legal Officer at a price of $24.94 per share. As a result of the transaction, Ring Christine now holds 24,592 shares, worth roughly $0.62 million.
Jefferies initiated its Nurix Therapeutics Inc [NRIX] rating to a Buy in a research note published on October 11, 2024; the price target was $41. Truist began covering NRIX with “Buy” recommendation on July 31, 2024.
Price Performance Review of NRIX
On Monday, Nurix Therapeutics Inc [NASDAQ:NRIX] saw its stock jump 6.47% to $25.16. Over the last five days, the stock has gained 16.81%. Nurix Therapeutics Inc shares have risen nearly 143.80% since the year began. Nevertheless, the stocks have risen 303.85% over the past one year. While a 52-week high of $26.31 was reached on 09/18/24, a 52-week low of $4.22 was recorded on 01/29/24. SMA at 50 days reached $23.27, while 200 days put it at $16.66.
Levels Of Support And Resistance For NRIX Stock
The 24-hour chart illustrates a support level at 23.74, which if violated will result in even more drops to 22.32. On the upside, there is a resistance level at 26.08. A further resistance level may holdings at 27.00. The Relative Strength Index (RSI) on the 14-day chart is 62.68, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.95, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 9.31%. Stochastics %K at 60.90% indicates the stock is a holding.
How much short interest is there in Nurix Therapeutics Inc?
A steep rise in short interest was recorded in Nurix Therapeutics Inc stocks on 2024-09-30, dropping by -0.18 million shares to a total of 9.08 million shares. Yahoo Finance data shows the prior-month short interest on 2024-08-30 was 9.26 million shares. There was a decline of -2.03%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on March 09, 2023 when Barclays began covering the stock and recommended ‘”an Overweight”‘ rating along with a $20 price target.
